Organogenesis Holdings Inc (ORGO)

Jan 27, 2025, 7:30 AM EST - 27 days ago

Organogenesis Holdings Inc. to Report Fourth Quarter of Fiscal Year 2024 Financial Results on February 27, 2025

Nov 22, 2024, 4:05 PM EST - 3 months ago

Organogenesis Expands Manufacturing Capacity to Support Future Growth

Nov 15, 2024, 9:25 AM EST - 3 months ago

Organogenesis Commends Final LCDs

Nov 12, 2024, 11:02 PM EST - 3 months ago

Organogenesis Holdings, Inc. (ORGO) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 4:01 PM EST - 3 months ago

Organogenesis Holdings Inc. Announces $130 Million Private Placement Offering of Series A Convertible Preferred Stock

Nov 11, 2024, 5:05 PM EST - 3 months ago

Organogenesis Reports Positive Interim Analysis of Second Phase 3 Clinical Trial of ReNu for Knee Osteoarthritis

Oct 16, 2024, 7:30 AM EDT - 4 months ago

Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2024 Financial Results on November 12, 2024

Oct 1, 2024, 4:05 PM EDT - 5 months ago

Organogenesis Announces Publication of Randomized Clinical Trial Results Demonstrating the Safety and Efficacy of NuShield for Diabetic Foot Ulcers

Sep 4, 2024, 4:05 PM EDT - 6 months ago

Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in September

Aug 8, 2024, 11:08 PM EDT - 7 months ago

Organogenesis Holdings, Inc. (ORGO) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 4:04 PM EDT - 7 months ago

Organogenesis Shares ReNu® Program Update

Jul 15, 2024, 4:05 PM EDT - 7 months ago

Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2024 Financial Results on August 8, 2024

Jun 6, 2024, 4:05 PM EDT - 9 months ago

Organogenesis Holdings Inc. to Participate in the Truist Securities MedTech Conference

May 9, 2024, 9:01 PM EDT - 10 months ago

Organogenesis Holdings, Inc. (ORGO) Q1 2024 Earnings Call Transcript

May 2, 2024, 7:00 AM EDT - 10 months ago

Organogenesis Achieves Primary Endpoint in Phase 3 Clinical Trial of ReNu® for Knee Osteoarthritis

Apr 16, 2024, 7:30 AM EDT - 11 months ago

Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024

Feb 29, 2024, 11:06 PM EST - 1 year ago

Organogenesis Holdings, Inc. (ORGO) Q4 2023 Earnings Call Transcript

Feb 29, 2024, 4:05 PM EST - 1 year ago

Organogenesis Holdings Inc. Reports Fourth Quarter 2023 and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Guidance

Feb 12, 2024, 7:30 AM EST - 1 year ago

Organogenesis Holdings Inc. to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference

Feb 8, 2024, 4:05 PM EST - 1 year ago

Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 29, 2024

Nov 9, 2023, 10:16 PM EST - 1 year ago

Organogenesis Holdings, Inc. (ORGO) Q3 2023 Earnings Call Transcript

Nov 9, 2023, 4:05 PM EST - 1 year ago

Organogenesis Holdings Inc. Reports Third Quarter 2023 Financial Results

Oct 5, 2023, 7:30 AM EDT - 1 year ago

Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2023 Financial Results on November 9, 2023

Sep 28, 2023, 9:15 AM EDT - 1 year ago

Organogenesis Applauds Withdrawal of Local Coverage Determinations by Novitas, First Coast Service Options and CGS

Sep 6, 2023, 4:05 PM EDT - 1 year ago

Organogenesis Holdings Inc. to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference

Aug 9, 2023, 4:05 PM EDT - 1 year ago

Organogenesis Holdings Inc. Reports Second Quarter 2023 Financial Results; Withdraws Fiscal Year 2023 Guidance

Jul 20, 2023, 11:31 AM EDT - 1 year ago

Organogenesis: Solid Revenue Generation From A Hyper-Trading Wound Care Company

Jul 10, 2023, 7:30 AM EDT - 1 year ago

Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2023 Financial Results on August 9, 2023

May 21, 2023, 8:20 AM EDT - 1 year ago

TipRanks reveals the top 10 health care sector analysts of the past decade

CABA CYH EXAS MRNA NVAX PFE RARE

May 10, 2023, 11:50 PM EDT - 1 year ago

Organogenesis Holdings Inc. (ORGO) Q1 2023 Earnings Call Transcript

May 10, 2023, 4:05 PM EDT - 1 year ago

Organogenesis Holdings Inc. Reports First Quarter 2023 Financial Results

Apr 27, 2023, 7:30 AM EDT - 1 year ago

Organogenesis President and Chief Executive Officer Gary S. Gillheeney, Sr. Elected Chair of the Board of Directors

Apr 10, 2023, 7:30 AM EDT - 2 years ago

Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2023 Financial Results on May 10, 2023

Mar 27, 2023, 8:00 AM EDT - 2 years ago

Organogenesis Applauds Findings from the Office of Inspector General

Mar 1, 2023, 10:17 PM EST - 2 years ago

Organogenesis Holdings Inc. (ORGO) Q4 2022 Earnings Call Transcript

Mar 1, 2023, 4:02 PM EST - 2 years ago

Organogenesis Holdings Inc. Reports Fourth Quarter 2022 and Fiscal Year 2022 Financial Results; Introduces Fiscal Year 2023 Guidance

Mar 1, 2023, 4:01 PM EST - 2 years ago

Organogenesis Reports Positive Interim Analysis of Phase 3 Clinical Trial of ReNu for Knee Osteoarthritis

Feb 9, 2023, 7:30 AM EST - 2 years ago

Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2022 Financial Results on March 1, 2023

Dec 5, 2022, 7:30 AM EST - 2 years ago

Organogenesis Holdings Inc. to Participate in the Cantor Fitzgerald Medical and Aesthetic Dermatology, Ophthalmology and Medtech Conference

Nov 9, 2022, 9:24 PM EST - 2 years ago

Organogenesis Holdings Inc. (ORGO) Q3 2022 Earnings Call Transcript

Nov 9, 2022, 4:05 PM EST - 2 years ago

Organogenesis Holdings Inc. Reports Third Quarter 2022 Financial Results

Oct 18, 2022, 4:53 AM EDT - 2 years ago

Organogenesis: Finding A Spot For This Regenerative Medicines Company In My 'Bio Boom' Portfolio

Sep 26, 2022, 9:12 AM EDT - 2 years ago

Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2022 Financial Results on November 9, 2022

Sep 7, 2022, 7:30 AM EDT - 2 years ago

Organogenesis Holdings Inc. to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference

Aug 15, 2022, 7:00 AM EDT - 2 years ago

Organogenesis Receives FDA Clearance for Next Generation PuraPly Surgical Solution

Aug 9, 2022, 6:50 PM EDT - 2 years ago

Organogenesis Holdings Inc. (ORGO) CEO Gary Gillheeney on Q2 2022 Results - Earnings Call Transcript